| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 203.89M | 2.65% |
| Operating expense | — | — |
| Net income | 17.84M | -13.74% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, OQS.F returned -18.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -18.2% |
| 1 year | -18.9% |
| 5 years | -55.0% |
| 10 years | -12.6% |
| All-time high | €4.82 (Dec 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in OQS.F would be worth today ›No. Nanosonics Limited has not paid a dividend in the past 12 months.
Nanosonics Limited is part of the Healthcare sector.
Nanosonics Limited has a market cap of 538.04M EUR, based on the latest quote.
